(Q45358273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

main subject

plasmablastic lymphoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Brady Beltrán

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mark Bower

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Roberto N. Miranda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Michele Bibas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

José Luis Díez-Martín

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

14

Julie M Vose

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Michael Furman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Weina Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jane J Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Silvia Montoto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nahid M Nanaji

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

José-Tomás Navarro

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Adam C Seegmiller

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

17 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

5270-5277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510767%20AND%20SRC:MED&resulttype=core&format=json

Plasmablastic lymphoma: a systematic review.

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

HIV-negative plasmablastic lymphoma: not in the mouth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27551

7 January 2021